Data / Drug companies / Par Health USA, LLC
Par Health USA, LLC: 35 products in the FDA NDC directory, labeler code 0603
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Par Health USA, LLC (labeler code 0603) lists 35 products in the FDA National Drug Code Directory, covering 14 finished drugs by generic name. By type: 33 prescription drugs, 2 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on March 17, 2022.
The request: Watch Par Health USA, LLC (FDA labeler code 0603): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 0603
- Products in commercial distribution
- 35
- Packages
- 65
- Finished drugs by generic name
- 14
- Prescription products
- 33
- Over the counter products
- 2
- Controlled substance products
- Schedule IV 4
- Flagged as original packager
- 24 of 24 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 7
- Earliest marketing start
- December 22, 1998
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 27 | 77.1% |
| Other unapproved drugs | 4 | 11.4% |
| Over the counter monograph drugs | 2 | 5.7% |
| Authorized generics (NDA) | 1 | 2.9% |
| New drug applications (NDA) | 1 | 2.9% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 33 | 94.3% |
| Over the counter drugs | 2 | 5.7% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Propranolol hydrochloride | 5 | 51 |
| Prednisone | 5 | 49 |
| Perphenazine | 4 | 18 |
| Phenobarbital | 4 | 25 |
| Benztropine mesylate | 3 | 22 |
| Felodipine | 3 | 15 |
| Baclofen | 2 | 65 |
| Allopurinol | 2 | 54 |
| Magnesium oxide | 2 | 13 |
| Lidocaine | 1 | 216 |
| Potassium chloride | 1 | 84 |
| Methylprednisolone | 1 | 31 |
| Dicyclomine hydrochloride | 1 | 50 |
| Butalbital and acetaminophen | 1 | 9 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 25 | 71.4% |
| Tablet, film coated | 4 | 11.4% |
| Tablet, extended release | 2 | 5.7% |
| Patch | 1 | 2.9% |
| Tablet, film coated, extended release | 1 | 2.9% |
| Powder, for solution | 1 | 2.9% |
| Solution | 1 | 2.9% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Benztropine Mesylate | 0603-2435 | Tablet | Generic drugs (ANDA) | March 17, 2022 |
| Benztropine Mesylate | 0603-2434 | Tablet | Generic drugs (ANDA) | March 17, 2022 |
| Benztropine Mesylate | 0603-2433 | Tablet | Generic drugs (ANDA) | March 17, 2022 |
| Magnesium Oxide | 0603-0213 | Tablet | Over the counter monograph drugs | November 10, 2020 |
| Potassium Chloride | 0603-1554 | Powder, for solution | New drug applications (NDA) | September 18, 2015 |
| Magnesium Oxide | 0603-0209 | Tablet | Over the counter monograph drugs | July 1, 2014 |
| Lidocaine | 0603-1880 | Patch | Authorized generics (NDA) | May 2, 2014 |
| Felodipine | 0603-3583 | Tablet, film coated, extended release | Generic drugs (ANDA) | December 15, 2011 |
| Felodipine | 0603-3582 | Tablet, extended release | Generic drugs (ANDA) | December 15, 2011 |
| Propranolol Hydrochloride | 0603-5486 | Tablet | Generic drugs (ANDA) | June 21, 2010 |
| Propranolol Hydrochloride | 0603-5485 | Tablet | Generic drugs (ANDA) | June 21, 2010 |
| Propranolol Hydrochloride | 0603-5484 | Tablet | Generic drugs (ANDA) | June 21, 2010 |
| Propranolol Hydrochloride | 0603-5483 | Tablet | Generic drugs (ANDA) | June 21, 2010 |
| Propranolol Hydrochloride | 0603-5482 | Tablet | Generic drugs (ANDA) | June 21, 2010 |
| Felodipine | 0603-3581 | Tablet, extended release | Generic drugs (ANDA) | March 31, 2009 |
| Baclofen | 0603-2407 | Tablet | Generic drugs (ANDA) | August 30, 2005 |
| Baclofen | 0603-2406 | Tablet | Generic drugs (ANDA) | August 30, 2005 |
| Dicyclomine hydrochloride | 0603-1161 | Solution | Generic drugs (ANDA) | June 23, 2005 |
| Prednisone | 0603-5336 | Tablet | Generic drugs (ANDA) | December 21, 2004 |
| Prednisone | 0603-5335 | Tablet | Generic drugs (ANDA) | December 21, 2004 |
| Allopurinol | 0603-2116 | Tablet | Generic drugs (ANDA) | June 27, 2003 |
| Allopurinol | 0603-2115 | Tablet | Generic drugs (ANDA) | June 27, 2003 |
| Prednisone | 0603-5339 | Tablet | Generic drugs (ANDA) | February 12, 2003 |
| Phenobarbital | 0603-5166 | Tablet | Other unapproved drugs | February 1, 2003 |
| Prednisone | 0603-5338 | Tablet | Generic drugs (ANDA) | July 12, 2002 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.